Cargando…

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

INTRODUCTION: The endocannabinoid (eCB) system disruption has been suggested to underpin the development of psychosis, fueling the search for novel, better-tolerated antipsychotic agents that target the eCB system. Among these, palmitoylethanolamide (PEA), an N-acylethanolamine (AE) with neuroprotec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortoletto, Riccardo, Piscitelli, Fabiana, Candolo, Anna, Bhattacharyya, Sagnik, Balestrieri, Matteo, Colizzi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390736/ https://www.ncbi.nlm.nih.gov/pubmed/37533892 http://dx.doi.org/10.3389/fpsyt.2023.1231710

Ejemplares similares

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
por: Colizzi, Marco, et al.
Publicado: (2022)

The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System
por: Colizzi, Marco, et al.
Publicado: (2022)

Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
por: Colizzi, Marco, et al.
Publicado: (2021)

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies
por: Kraeuter, Ann-Katrin, et al.
Publicado: (2020)

Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy
por: Comacchio, Carla, et al.
Publicado: (2023)

S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2018)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior
por: Colizzi, Marco, et al.
Publicado: (2020)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

A Preliminary Investigation of the Views of People With Parkinson's (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey
por: McGoohan, Katie, et al.
Publicado: (2020)

Alcohol binge drinking in adolescence and psychological profile: Can the preclinical model crack the chicken-or-egg question?
por: Castelli, Valentina, et al.
Publicado: (2022)

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Pathways from Cannabis to Psychosis: A Review of the Evidence
por: Burns, Jonathan K.
Publicado: (2013)

Minimizing policy-biased appraisals of the evidence on cannabis and psychosis
por: Hall, Wayne
Publicado: (2023)

Sexuality in Ultra-High Risk for Psychosis and First-Episode Psychosis. A Systematic Review of Literature
por: Ciocca, Giacomo, et al.
Publicado: (2021)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

Cannabinoids, reward processing, and psychosis
por: Gunasekera, Brandon, et al.
Publicado: (2021)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

Predictors of Outcomes in Adolescents With Clinical High Risk for Psychosis, Other Psychiatric Symptoms, and Psychosis: A Longitudinal Protocol Study
por: Molteni, Silvia, et al.
Publicado: (2019)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
por: Cordaro, Marika, et al.
Publicado: (2020)

Inequality and barriers in psychosis prevention: A systematic review on clinical high-risk for psychosis studies from developing countries
por: Loch, Alexandre Andrade, et al.
Publicado: (2023)

F102. CHANGE IN PATTERNS OF CANNABIS AND OTHER SUBSTANCE USE OVER TIME IN EARLY PSYCHOSIS- EXAMINING THE EFFECT OF DEVELOPMENT OF PSYCHOSIS
por: Sami, Musa, et al.
Publicado: (2018)

Oxytocin as a treatment for high-risk psychosis or early stages of psychosis: a mini review
por: Bargiota, Stavroula I., et al.
Publicado: (2023)

Perspectives on Games, Computers, and Mental Health: Questions about Paradoxes, Evidences, and Challenges
por: Desseilles, Martin
Publicado: (2016)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Vascular-related biomarkers in psychosis: a systematic review and meta-analysis
por: Li, Xiaojun, et al.
Publicado: (2023)

Mentalizing in individuals with state and trait risk for psychosis: a systematic review
por: De Salve, Francesca, et al.
Publicado: (2023)

Editorial: Methods and applications in addiction psychiatry research: 2021
por: Colizzi, Marco, et al.
Publicado: (2022)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
por: Petrosino, Stefania, et al.
Publicado: (2018)

Efficacy of a Group Psychoeducation Treatment in Binge Eating Disorder: An Open-Label Study
por: Liquori, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cv8fn2pna4uokcg73srhabilf7